{"id":9727,"date":"2021-04-04T17:09:28","date_gmt":"2021-04-04T10:09:28","guid":{"rendered":"https:\/\/illume-emag.com\/?p=9727"},"modified":"2021-04-10T20:14:43","modified_gmt":"2021-04-10T13:14:43","slug":"us-stops-astrazeneca-vaccine-production-baltimore-plant","status":"publish","type":"post","link":"https:\/\/lavyon.com\/en\/us-stops-astrazeneca-vaccine-production-baltimore-plant\/","title":{"rendered":"US stops AstraZeneca vaccine production at Baltimore plant"},"content":{"rendered":"<p style=\"text-align: justify;\">The new decision, made by the Ministry of Health and Human Services, aims to have the Emergent BioSolutions plant in Baltimore focus entirely on Johnson &amp; Johnson&#8217;s Covid-19 vaccine production. It also avoids the same manufacturing problems as happened with the 15 million doses of Johnson &amp; Johnson vaccine.<\/p>\n<figure id=\"attachment_9728\" aria-describedby=\"caption-attachment-9728\" style=\"width: 800px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9728\" src=\"http:\/\/lavyon.com\/wp-content\/uploads\/2021\/04\/1259efdaffcc9482849b9e0892e7dbda.jpg\" alt=\"US stops AstraZeneca vaccine production at Baltimore plant\" width=\"800\" height=\"443\" title=\"\" srcset=\"https:\/\/lavyon.com\/wp-content\/uploads\/2021\/04\/1259efdaffcc9482849b9e0892e7dbda.jpg 800w, https:\/\/lavyon.com\/wp-content\/uploads\/2021\/04\/1259efdaffcc9482849b9e0892e7dbda-150x83.jpg 150w, https:\/\/lavyon.com\/wp-content\/uploads\/2021\/04\/1259efdaffcc9482849b9e0892e7dbda-300x166.jpg 300w, https:\/\/lavyon.com\/wp-content\/uploads\/2021\/04\/1259efdaffcc9482849b9e0892e7dbda-696x385.jpg 696w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><figcaption id=\"caption-attachment-9728\" class=\"wp-caption-text\">AstraZeneca&#8217;s Covid-19 vaccine. Photo: Reuters<\/figcaption><\/figure>\n<p style=\"text-align: justify;\">Earlier, on March 31, the New York Times reported that 15 million doses of Covid-19 vaccine of Johnson &amp; Johnson pharmaceutical company were damaged during production at the Emergent BioSolutions factory in Baltimore.<\/p>\n<p style=\"text-align: justify;\">Johnson &amp; Johnson later confirmed there was a batch of substandard drugs. However, this batch of pharmaceutical substance has not been put into the final stages of the production line.<\/p>\n<p style=\"text-align: justify;\">Pharmaceutical company Johnson &amp; Johnson also decided to add experts in production, professional operations and quality to Emergent factory to supervise, direct and support all production stages of Covid-19 vaccine.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The new decision, made by the Ministry of Health and Human Services, aims to have the Emergent BioSolutions plant in Baltimore focus entirely on Johnson &amp; Johnson&#8217;s Covid-19 vaccine production. It also avoids the same manufacturing problems as happened with the 15 million doses of Johnson &amp; Johnson vaccine. Earlier, on March 31, the New [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":9728,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2892],"tags":[5254,5256,2490,2438,2440,2630,2488,2289],"class_list":{"0":"post-9727","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-from-zero-to-hero","8":"tag-astrazeneca-vaccine","9":"tag-baltimore-plant","10":"tag-illume-en","11":"tag-illume-e-magazine-online-cover","12":"tag-illume-emag-en","13":"tag-illume-mag-en","14":"tag-illume-magazine","15":"tag-us"},"_links":{"self":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/posts\/9727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/comments?post=9727"}],"version-history":[{"count":0,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/posts\/9727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/media\/9728"}],"wp:attachment":[{"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/media?parent=9727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/categories?post=9727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lavyon.com\/en\/wp-json\/wp\/v2\/tags?post=9727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}